We are live on ! Find out more
HPG

Harvest Portfolios Group Portfolio holdings

AUM $7.09B
1-Year Est. Return 20.73%
This Fund
S&P 500
This Quarter Est. Return
+12.07%
1 Year Est. Return
+20.73%
3 Year Est. Return
+67.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.74B
AUM Growth
–
Cap. Flow
+$1.71B
Cap. Flow %
98.49%
Top 10 Hldgs %
29.01%
Holding
178
New
177
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$59.9M
2
UNH icon
UnitedHealth
UNH
+$57.4M
3
ZTS icon
Zoetis
ZTS
+$49.7M
4
TMO icon
Thermo Fisher Scientific
TMO
+$46.1M
5
ABBV icon
AbbVie
ABBV
+$45.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 54.59%
2 Technology 16.36%
3 Financials 8.18%
4 Consumer Discretionary 5.78%
5 Communication Services 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
JNJ icon
1
Johnson & Johnson
JNJ
$617B
$61.2M 3.52%
+346,707
New +$59.9M
2022 Q4
0 quarters
UNH icon
2
UnitedHealth
UNH
$334B
$57.4M 3.3%
+108,275
New +$57.4M
2022 Q4
0 quarters
ZTS icon
3
Zoetis
ZTS
$28.8B
$49.2M 2.83%
+335,987
New +$49.7M
2022 Q4
0 quarters
AZN icon
4
AstraZeneca
AZN
$243B
$48.7M 2.8%
+359,097
New +$45M
2022 Q4
0 quarters
MRK icon
5
Merck
MRK
$356B
$48.6M 2.79%
+437,740
New +$44.7M
2022 Q4
0 quarters
ABBV icon
6
AbbVie
ABBV
$464B
$48.3M 2.78%
+299,120
New +$45.9M
2022 Q4
0 quarters
TMO icon
7
Thermo Fisher Scientific
TMO
$242B
$47.9M 2.75%
+86,909
New +$46.1M
2022 Q4
0 quarters
ABT icon
8
Abbott
ABT
$169B
$47.8M 2.75%
+435,715
New +$45.1M
2022 Q4
0 quarters
ISRG icon
9
Intuitive Surgical
ISRG
$138B
$47.8M 2.75%
+180,127
New +$43.9M
2022 Q4
0 quarters
SYK icon
10
Stryker
SYK
$106B
$47.6M 2.74%
+194,707
New +$44.2M
2022 Q4
0 quarters
BSX icon
11
Boston Scientific
BSX
$61.7B
$47.3M 2.72%
+1,021,516
New +$44.2M
2022 Q4
0 quarters
PFE icon
12
Pfizer
PFE
$158B
$47M 2.7%
+917,358
New +$44M
2022 Q4
0 quarters
NVS icon
13
Novartis
NVS
$268B
$46.9M 2.7%
+517,129
New +$43.6M
2022 Q4
0 quarters
DHR icon
14
Danaher
DHR
$150B
$46.5M 2.67%
+197,663
New +$45.8M
2022 Q4
0 quarters
LLY icon
15
Eli Lilly
LLY
$1.02T
$46.3M 2.66%
+126,548
New +$44.9M
2022 Q4
0 quarters
AMGN icon
16
Amgen
AMGN
$218B
$44.1M 2.53%
+167,861
New +$45M
2022 Q4
0 quarters
REGN icon
17
Regeneron Pharmaceuticals
REGN
$75.7B
$42.9M 2.47%
+59,463
New +$43.9M
2022 Q4
0 quarters
BMY icon
18
Bristol-Myers Squibb
BMY
$125B
$42.3M 2.43%
+588,165
New +$44.3M
2022 Q4
0 quarters
ELV icon
19
Elevance Health
ELV
$83.8B
$41.7M 2.4%
+81,386
New +$41.3M
2022 Q4
0 quarters
MDT icon
20
Medtronic
MDT
$110B
$39.4M 2.27%
+507,240
New +$41.1M
2022 Q4
0 quarters
V icon
21
Visa
V
$677B
$29.7M 1.71%
+142,783
New +$28.8M
2022 Q4
0 quarters
MSFT icon
22
Microsoft
MSFT
$3.84T
$28.5M 1.64%
+118,804
New +$28.5M
2022 Q4
0 quarters
ACN icon
23
Accenture
ACN
$122B
$27.1M 1.56%
+101,708
New +$28.1M
2022 Q4
0 quarters
INTC icon
24
Intel
INTC
$631B
$27M 1.55%
+1,020,125
New +$28.3M
2022 Q4
0 quarters
GOOGL icon
25
Alphabet (Google) Class A
GOOGL
$4.2T
$25M 1.44%
+283,300
New +$26.9M
2022 Q4
0 quarters
1
2 3 4 5

Similar funds

CGPCS
Capital Group Private Client Services Los Angeles, California $7.09B AUM 30.53% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
SAM
Scopus Asset Management New York $7.11B AUM 32.62% 1-Year Est. Return
EWM
Evercore Wealth Management New York $7.07B AUM 24.72% 1-Year Est. Return
BFS
Bradley Foster & Sargent Hartford, Connecticut $7.06B AUM 27.24% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $7.06B AUM 36.47% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM

Harvest Portfolios Group's Q4 2022 Portfolio in Review

Q4 2022 is the first quarter with a 13F filing on record for Harvest Portfolios Group, which disclosed 178 positions worth $1.74B. Its ten largest holdings account for 29% of the portfolio.

Its largest position is Johnson & Johnson: 346,707 shares worth $61.2M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, followed by Technology and Financials.

  • Harvest Portfolios Group's largest Q4 2022 buy was Johnson & Johnson: 346,707 shares worth $61.2M.
  • Harvest Portfolios Group's ten largest holdings make up 29% of its $1.74B portfolio in Q4 2022.
  • Harvest Portfolios Group disclosed 178 positions in Q4 2022, its first 13F filing on record.

Based on Harvest Portfolios Group's 13F filing for Q4 2022, filed 14 Feb 2023.